Improve speech clarity with feedback
- Trial ID
- NCT06540989
- Official Title
- Understand Me for Life: Using Noise-augmented Automatic Speech Recognition to Improve Intelligibility in Parkinson's Disease
- Goal
- Improve speech clarity with feedback
- Phase
- EARLY_PHASE1
- Status
- RECRUITING
- Sponsor
- Teachers College, Columbia University
- Study Type
- INTERVENTIONAL
- Enrollment
- 42 participants
- Conditions
- Parkinson Disease
- Interventions
- Immediate treatment, Deferred treatment
Plain-Language Summary
Understand Me for Life aims to make everyday speech clearer for people with Parkinson's who have mild to moderate trouble being understood, so conversations feel less tiring and more effective. It uses an automatic speech recognition system trained with noise-augmented audio to objectively measure intelligibility and give real-time feedback, helping participants practice louder, clearer articulation and better pacing; some start the program right away and others start later so outcomes can be compared. The trial is looking for people 50 to 80 years old with Parkinson's at Hoehn and Yahr stages I to IV, stable antiparkinsonian meds, a Mini‑Mental State Exam score of 25 or higher, and mild to moderate dysarthria. People with atypical parkinsonism, deep brain stimulation, recent intensive voice therapy, or unrelated speech or voice disorders are not eligible.
Locations
- Teachers College, Columbia University, New York, New York, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Immediate treatment. Understand Me for Life aims to make everyday speech clearer for people with Parkinson's who have mild to moderate trouble being understood, so conversations feel less tiring and more effective. It uses an automatic speech recognition system trained with noise-augmented audio to objectively measure intelligibility and give real-time feedback, helping participants practice louder, clearer articulation and better pacing; some start the program right away and others start later so outcomes can be compared. The trial is looking for people 50 to 80 years old with Parkinson's at Hoehn and Yahr stages I to IV, stable antiparkinsonian meds, a Mini‑Mental State Exam score of 25 or higher, and mild to moderate dysarthria. People with atypical parkinsonism, deep brain stimulation, recent intensive voice therapy, or unrelated speech or voice disorders are not eligible.
- Who can participate?
- Participants must be between 50 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This Phase 1 trial is estimated to last approximately 1 year and 5 months.